(2022). Transparency of high-dimensional propensity score analyses: guidance for diagnostics and reporting. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5412.
(2015). BMI and risk of dementia in two million people over two decades: a retrospective cohort study. Lancet Diabetes Endocrinol. http://doi.org/10.1016/s2213-8587(15)00033-9.
(2020). Implementing high-dimensional propensity score principles to improve confounder adjustment in UK electronic health records. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5121.